AHS Cancer Control Alberta

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant

Conditions
Prostate Cancer
First Posted Date
2011-09-20
Last Posted Date
2017-01-25
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
25
Registration Number
NCT01437085
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Breast Cancer and Exercise Trial in Alberta

Not Applicable
Completed
Conditions
Breast Neoplasms
Interventions
Other: High Volume
Other: Moderate Volume
First Posted Date
2011-09-15
Last Posted Date
2018-01-30
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
400
Registration Number
NCT01435005
Locations
🇨🇦

Tom Baker Cancer Centre, Calgary, Alberta, Canada

🇨🇦

Cross Cancer Centre, Edmonton, Alberta, Canada

Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
First Posted Date
2011-09-05
Last Posted Date
2017-01-25
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
8
Registration Number
NCT01428739
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer

Phase 1
Conditions
Small Cell Lung Cancer
First Posted Date
2011-09-01
Last Posted Date
2014-10-02
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
10
Registration Number
NCT01426841
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Not Applicable
Conditions
Pancreas Cancer
Interventions
Drug: gemcitabine
Drug: 5-fluorouracil
First Posted Date
2011-08-08
Last Posted Date
2014-10-03
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
20
Registration Number
NCT01411072
Locations
🇨🇦

Tom Baker Cancer Center, Calgary, Alberta, Canada

🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

TORI 104 Pre-Surgical Dasatinib

Phase 2
Withdrawn
Conditions
Breast Cancer
First Posted Date
2011-08-05
Last Posted Date
2016-02-17
Lead Sponsor
AHS Cancer Control Alberta
Registration Number
NCT01410708
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences

Conditions
Prostate Cancer
First Posted Date
2011-05-18
Last Posted Date
2014-10-03
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
20
Registration Number
NCT01355185
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

First Posted Date
2010-07-05
Last Posted Date
2014-10-01
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
15
Registration Number
NCT01157052
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

First Posted Date
2010-07-05
Last Posted Date
2016-02-24
Lead Sponsor
AHS Cancer Control Alberta
Registration Number
NCT01157039

A Feasibility Study to Compare the Benefits of Endoscopic Tumor Clip Placement and 3T-MRI Simulation for Accurate Target Volume Definition for Rectal Cancer Patients Undergoing Pre-operative Chemoradiation

Not Applicable
Completed
Conditions
Rectal Cancer
First Posted Date
2010-05-28
Last Posted Date
2014-10-02
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
10
Registration Number
NCT01133340
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy